MedPath

Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic

Completed
Conditions
Anxiety
Depression
COVID-19
Pregnancy Complications
Ptsd
Mental Health Wellness 1
Coronavirus
Interventions
Other: This is an online survey with no intervention.
Registration Number
NCT04385238
Lead Sponsor
Pregistry
Brief Summary

The purpose of this study is to assess the health and wellbeing of pregnant and recently pregnant women during the COVID-19 pandemic using an online survey.

Detailed Description

Millions of women will give birth during the pandemic of Coronavirus Disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The consequences of COVID-19 for pregnant women and their offspring are unknown. This lack of information leads to anxiety among pregnant women, women who are considering getting pregnant, and their families. It is therefore important to assess the wellbeing and mental health of women during the COVID-19 pandemic.

The international nature of the online survey will allow the evaluation of how living during the COVID-19 pandemic affects pregnant and recently pregnant women at a global level, including the evaluation of potential cultural and geographic differences.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
6894
Inclusion Criteria
  • Pregnant women or women who have been pregnant within the last 6 months
  • Able to give electronic informed consent
Exclusion Criteria
  • <18 years of age

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Pregnant WomenThis is an online survey with no intervention.Pregnant women who are 18 years of age or older.
Post-partum womenThis is an online survey with no intervention.Women who gave birth within the last 6 months who are 18 years of age or older.
Primary Outcome Measures
NameTimeMethod
Number of Participants With Symptoms of Anxiety and DepressionAnytime during pregnancy or within 6 months after given birth.

Symptoms of anxiety and depression will be measured by the Patient Health Questionnaire-4 (PHQ-4) which combines two ultrabrief screeners: the PHQ-2 and the Generalised Anxiety Disorder Scale. Participants will be asked to report their symptoms of depression and anxiety in the past 2 weeks on a Likert Scale from 0 (not at all) to 3 (nearly every day) for a maximum score of 12.

Number of Participants With Symptoms of Post-traumatic Stress DisorderAnytime during pregnancy or within 6 months after given birth.

Post-traumatic Stress Disorder (PTSD) Symptoms will be assessed by the Impact of Events Scale-6. This scale includes a total of six items: two items from each of the three subscales of the measure, namely intrusion, hyperarousal and avoidance. Participants will be asked to report their PTSD symptoms in the past 7 days on a Likert Scale ranging from 0 (not at all) to 4 (extremely).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Pregistry

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath